AK

Amrish Kumar Gupta

Director Director DIN 06488972
DIN 06488972 First appointment May 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Amrish Kumar Gupta

Data last updated:

Amrish Kumar Gupta was a Director at Vicinity Pharmaceutical Private Limited (2014–2015) and Director at Pro Cure Life Science Private Limited (2013). The companies operate in Pharma and Healthcare.

DIN 06488972
Primary Designation Director
Industry Pharma
First Appointment 06 May 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Sep 20142014₹5.4 Lakh (FY 2017)Strike Off
Director06 May 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vicinity Pharmaceutical Private Limited
Pro Cure Life Science Private Limited
Premium access

Shareholding and investment profile for Amrish Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amrish Kumar Gupta

Amrish Kumar Gupta was first appointed on 06 May 2013 as Director at Pro Cure Life Science Private Limited. The most recent appointment on record is 16 Sep 2014 at Vicinity Pharmaceutical Private Limited.

Amrish Kumar Gupta held 2 earlier board appointments: Vicinity Pharmaceutical Private Limited (Director, 16 Sep 2014 to 16 Oct 2015); Pro Cure Life Science Private Limited (Director, 06 May 2013 to 04 Jul 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available